| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Sep―21 |
Post COVID-19 War Era, Overall Updates and Upgrades Needed to Protect Patients Against Unpredictable Disease’s Progression |
Bahram Alamdary Badlou |
| 2 |
[GO] |
2023―Nov―04 |
Dose-dependent Oxidative Damage of Molnupiravir (Antiviral Drug for Treatment of COVID-19) in Lung, Liver, Heart, and Kidney Tissues in Rats |
Kevser TANBEK, Suleyman SANDAL |
| 3 |
[GO] |
2023―Apr―20 |
Reflections on COVID-19 Pharmacological Treatment and Beyond: Beware of “Salads” with Many Ingredients but Low Scientific Content |
Jose Luis Turabian |
| 4 |
[GO] |
2023―Apr―20 |
Keeping Ready against Omicron and Future Variants: Can Ivermectin Prophylactic Effects Improve the Vaccination Effects against COVID-19? |
Hamidreza Zalpoor, Mohsen Nabi-Afjadi, Fatemeh Aziziyan, Chanour Tavakol |
| 5 |
[GO] |
2023―Apr―20 |
POSTCOVID-19WAR Era, Interaction between Cancer-Hematologic Disorders- Diabetes Significantly Increased by COVID-19 Variants, Aggressively |
Bahram Alamdary Badlou |
| 6 |
[GO] |
2023―Apr―20 |
The Role of the General Practitioner in Vaccination against COVID-19 |
Jose Luis Turabian |
| 7 |
[GO] |
2022―Nov―08 |
Relative COVID-19 Vaccine Booster Effectiveness and Clinical- Epidemiological Characteristics Before and After 29 Days of Shot |
|
| 8 |
[GO] |
2021―Oct―20 |
Remdesivir in COVID-19 Patients with End Stage Renal Disease on Hemodialysis |
|
| 9 |
[GO] |
2021―Oct―20 |
ProLung™-budesonide Inhibits SARS-CoV-2 Replication and Reduces Lung Inflammation |
|
| 10 |
[GO] |
2021―May―11 |
The Use of Hydroxychloroquine and Interferons for the Prophylaxis of COVID-19 |
|
| 11 |
[GO] |
2021―May―11 |
COVID-19 and the Health of Illicit Substance Users: Preliminary Analysis from Illicit Drug Transaction Data |
|
| 12 |
[GO] |
2021―May―11 |
COVID-19 Disease and SARS-CoV-2 Vaccination in Patients with Cancer |
|
| 13 |
[GO] |
2021―May―11 |
COVID-19 Rapid Diagnostic Test Results and their Associations with Certain Factors Among the Residents of Balochistan |
|
| 14 |
[GO] |
2021―Feb―25 |
Dexamethasone: The First Drug to be Shown to Decrease Mortality in Critically Ill Patients with COVID-19 |
|
| 15 |
[GO] |
2021―Feb―25 |
Classical Drug and its New Role in COVID-19 Management |
|
| 16 |
[GO] |
2021―Feb―25 |
Beta-Sitosterol: As Immunostimulant, Antioxidant and Inhibitor of SARS-CoV-2 Spike Glycoprotein |
|
